Neuroimaging–genetic work extends this evidence, with NTRK2 rs1948308 carriers exhibiting smaller hippocampal volumes and increased resistance; mediation analyses confirm hippocampal atrophy as a biological pathway linking genotype to clinical outcome [45]. The gene discussed is NTRK2; the disease is hippocampal atrophy.